Search Result "SGLT2inhibitors"
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2013 Page: 203-206
Author(s): Sarmad Said,German T. Hernandez
Cellular and Mitochondrial Pathways Contribute to SGLT2Inhibitors-mediated Tissue Protection: Experimental and Clinical Data
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 13 Year: 2024 Page: 969-974
Author(s): Sebastián GarcÃa Menéndez
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitorsin the Diabetic Milieu
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 138-151
Author(s):
Drug Metabolizing Enzymes in Type II Diabetes and their Pharmacogenetics During Therapy of Anti-Diabetes Drugs
Journal: Current Drug Metabolism
Volume: 16 Issue: 10 Year: 2015 Page: 864-876
Author(s): Chiranjib Chakraborty,Minna J. Hsu,Govindasamy Agoramoorthy
Emerging Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 2 Year: 2016
Author(s): Shivaprasad Channabasappa,Krishnan M. Prasanna Kumar
Doi: 10.2174/9781681081854116020007
Influence of SGLT2 Inhibitors in Remodeling, Substrate and Ion Metabolismof Myocardium to Prevent Cardiovascular Risks: Recent Work andAdvancement
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 5 Year: 2023 Page: 580-591
Author(s): Prithpal Sing Matreja,Ashok Kumar Parida,Susanta Nath Sarma
Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon
Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1051-1057
Author(s): Dylan Y. Ren,Yingmei Zhang
A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 3 Year: 2020 Page: 328-334
Author(s): Habib Yaribeygi,Stephen L. Atkin,Tannaz Jamialahmadi,Amirhossein Sahebkar
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 96-102
Author(s): V. Tsimihodimos, T.D. Filippatos, S. Filippas-Ntekouan, M. Elisaf
Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-Of-The-Art Review
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2022 Page: 1-13
Author(s): Mauro Gitto,Dimitrios A. Vrachatis,Gianluigi Condorelli,Konstantinos Papathanasiou,Bernhard Reimers,Spyridon Deftereos,Giulio G Stefanini